Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
The EMBO Journal23h
A CRISPR-Cas9 screen reveals genetic determinants of the cellular response to decitabine
A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...
TheSportster on MSN15h
16 Best American Boxers of All Time, Ranked
These are the greatest American boxers who captured multiple world titles, became global stars and stood out among the rest.
ESPN23h
Champions League knockout rounds: bracket, draws, dates, fixtures
The draw for the knockout playoff round of the new-look UEFA Champions League has been made. But how does this feed into the round-of-16 ties? When is the next draw? How does it all knit together?